Filter by
Filter by
Translating ConformalFLASH® from Research to Reality
In this webinar, you will explore the latest developments of proton ConformalFLASH therapy, and discover how ConformalFLASH is poised to revolutionize...
The Future of Proton Dosimetry with IBA: PBS Commissioning, Machine QA and Patient QA
What is on the horizon with IBA Dosimetry and Proton Therapy? Watch this webinar to learn about QA and how it will be integrated with our future developments.
Efficacy and toxicity of photon, proton, and carbon ion radiotherapy in the treatment of intracranial solitary fibrous tumor/hemangiopericytoma.
This study from the Heidelberg group reported results of 34 patients (12 patients of recurrence) with CNS solitary fibrous tumors (SFT) treated with photon...
Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
This review included 10 studies representing 1,718 patients. A pooled analysis was performed to evaluate the relationship between lymphopenia and overall...
Longitudinal Assessment of Quality of Life in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Proton Therapy and Volumetric Modulated Arc Therapy at Different Time Points.
This is a longitudinal assessment of QoL on 287 NPC patients treated with IMPT (n=41) and VMAT (n=246). Both groups exhibited improved scores of global QoL...
Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study.
This study from Japan reported clinical outcomes of 43 patient with operable stage IA or IB NSCLC treated with a dose of 66 GyRBE in 10 fractions for peripheral...
Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer.
This study by the Samsung group, Korea, reported clinical outcomes of 27 patients with inoperable early stage NSCLC treated by protons to a total dose of 64...
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis. This review.
Published in the Green Journal, this systematic review analyzed 160 studies of hypofractionated PT (n=11) or XRT (n=148) or PT+XRT (n=1) for localized prostate...